Question 1

What is the catalog number for Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) (FITC) discontinued?

Accepted Answer

The catalog number for Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) (FITC) discontinued is R1450-03F3.

Question 2

What sizes are available for Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) (FITC) discontinued?

Accepted Answer

Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) (FITC) discontinued is available in the following size(s): 100 µg.

Question 3

Is Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) (FITC) discontinued in stock?

Accepted Answer

Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) (FITC) discontinued

Selected Variant

R1450-03F3

Size: 100 µg

Product Specifications

Clonality

Mab

Question 4

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Question 5

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

Question 6

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.